Darunavir: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2026

10 March 2026

  • curprev 23:1323:13, 10 March 2026‎ Ostermayer talk contribs‎ 6,869 bytes +6,869‎ Created page with "Darunavir is an HIV-1 protease inhibitor (PI) with potent activity against both wild-type and PI-resistant HIV-1. It '''must''' be coadministered with a pharmacokinetic booster — either ritonavir or cobicistat — and taken with food.<ref name="PrezistaPI">Prezista (darunavir) [prescribing information]. Titusville, NJ: Janssen Therapeutics; 2017.</ref> ==Administration== *Type: HIV-1 protease inhibitor (PI) *Dosage Forms: 75 mg, 150 mg, 300 mg, 400 mg, 600 mg, 800 mg..."
Retrieved from "https://www.wikem.org/wiki/Darunavir"